Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5080234
Max Phase: Preclinical
Molecular Formula: C42H70N12O10
Molecular Weight: 903.10
Molecule Type: Unknown
Associated Items:
ID: ALA5080234
Max Phase: Preclinical
Molecular Formula: C42H70N12O10
Molecular Weight: 903.10
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C42H70N12O10/c1-23(2)21-31(37(59)48-24(3)34(56)51-30(41(63)64)16-11-19-47-42(45)46)52-35(57)25(4)49-39(61)33(26(5)55)53-38(60)32-17-12-20-54(32)40(62)29(15-9-10-18-43)50-36(58)28(44)22-27-13-7-6-8-14-27/h6-8,13-14,23-26,28-33,55H,9-12,15-22,43-44H2,1-5H3,(H,48,59)(H,49,61)(H,50,58)(H,51,56)(H,52,57)(H,53,60)(H,63,64)(H4,45,46,47)/t24-,25+,26-,28+,29+,30+,31+,32+,33+/m1/s1
Standard InChI Key: FRROZNKYJOKDQA-JRHISNECSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 903.10 | Molecular Weight (Monoisotopic): 902.5338 | AlogP: -2.60 | #Rotatable Bonds: 27 |
Polar Surface Area: 366.38 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.61 | CX LogP: -4.64 | CX LogD: -7.55 |
Aromatic Rings: 1 | Heavy Atoms: 64 | QED Weighted: 0.02 | Np Likeness Score: 0.17 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):